West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 316.59 USD -1.34% Market Closed
Market Cap: 22.9B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

30.8
Current
30.3
Median
18.6
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
30.8
=
Enterprise Value
22.7B USD
/
EBITDA
736.4m USD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
31.3
2-Years Forward
EV/EBITDA
26.7
3-Years Forward
EV/EBITDA
23.1

See Also

Discover More